AR and neoplasm: Kaplan Meier curves in Figure 3 shows that patients with AR+ tumor experienced a significantly worse late outcome as compared to AR- patients: late-DDFS rate at 5 years from the 3-years landmark were 75.8% for AR+ patients and 95.2% for AR- patients (log-rank p < 0.001).